Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

35
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
35
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

21
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
21
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

497
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
497
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.2K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.2K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.8K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.8K
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

20
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
20

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Esophageal epithelial cell-derived kynurenine drives Th17 inflammation in reflux esophagitis and is targeted by Xuanfu Daizhe decoction.

Chinese medicine·2026
Same author

Dioscin suppresses colitis-associated colorectal tumorigenesis by inhibiting PPARγ-mediated fatty acid oxidation in TAMs.

International immunopharmacology·2026
Same author

Urban Expansion and Butterfly Diversity: The Synergistic Effects of Impervious Surface and Vegetation Cover.

Insects·2026
Same author

Bridging data and discovery: a survey on knowledge graphs in AI for science.

National science review·2026
Same author

Integrated UPLC-QTOF-MS and Network Pharmacology for Predicting Active Constituents and Pharmacological Mechanisms of Yinxingye Tablets Against Oxidative Stress.

Biomedical chromatography : BMC·2026
Same author

Metabolomics Integrated with Mass Spectrometry Imaging Reveals Novel Action of Rb1 in Ischemic Stroke.

Journal of proteome research·2026

Related Experiment Video

Updated: Feb 18, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.2K

Transformer-based graphs for drug-drug interaction with chemical knowledge embedding.

Jinlu Zhang1,2, Xuting Zhang1,2, Yizheng Dai2

  • 1Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Xihu District, Hangzhou 310058, Zhejiang, China.

Briefings in Bioinformatics
|February 16, 2026
PubMed
Summary

Researchers developed TRACE, a transformer-based framework for predicting drug-drug interactions (DDIs). This interpretable model integrates chemical knowledge to identify high-risk substructures, improving drug safety and development.

Keywords:
chemical knowledgedrug–drug interactionmolecular graph

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.6K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.6K

Related Experiment Videos

Last Updated: Feb 18, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.2K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.6K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.6K

Area of Science:

  • Pharmacology
  • Computational Chemistry
  • Artificial Intelligence

Background:

  • Drug-drug interactions (DDIs) pose significant medical risks, necessitating accurate identification methods.
  • Deep learning enhances DDI prediction but often lacks chemical information integration and interpretability.
  • Current models struggle to elucidate the mechanisms behind DDIs.

Purpose of the Study:

  • To introduce TRACE, a novel transformer-based graph representation learning framework for DDI prediction.
  • To integrate chemical knowledge and enhance the interpretability of DDI prediction models.
  • To improve the accuracy and generalization ability of DDI prediction.

Main Methods:

  • Developed TRACE, a transformer-based graph representation learning framework.
  • Integrated chemical knowledge into the model architecture.
  • Utilized an attention mechanism for interpretability and substructure identification.

Main Results:

  • TRACE demonstrated superior performance compared to state-of-the-art models in both in-distribution and out-of-distribution settings.
  • The framework successfully identified high-risk chemical substructures associated with DDIs.
  • Achieved strong predictive performance and generalization ability.

Conclusions:

  • TRACE offers a robust and interpretable approach for DDI prediction.
  • The model enhances understanding of DDI mechanisms through substructure analysis.
  • TRACE supports safer drug development and informs combination therapy strategies.